SOME APPROACHES TO IMPROVING THE EFFECTIVENESS OF TREATMENT FOR DRUG ADDICTION PATIENTS
Keywords:
drug addiction, intensity, remission, frequency, cognitive-behavioral therapy, effectivenessAbstract
Introduction. Regional assessment of the severity of drug addiction, relapse rates, achievement of remission, and treatment effectiveness is of great scientific and practical importance. Objective. To evaluate the effectiveness of medical care using a cognitive-behavioral therapeutic (CBT) approach to treating patients with drug addiction (DA). Research materials and methods. Data on the incidence of new cases of DA and remission rates in the Samarkand region from 2010 to 2024. Treatment outcomes for 105 patients receiving a combination of detoxification and CBT, and 106 patients receiving detoxification alone. The study utilized clinical, epidemiological, social and hygienic, and laboratory-statistical methods. Results and discussion. For the period 2010–2024, the average incidence rate of DA was 5.1, decreasing by 1.7 times in 2024 (6.8) compared to 2010 (11.5). However, since 2018, the region has seen a new surge in the incidence of DA. The rate of remission lasting ≥6 months in patients with DA decreased by 1.3 times (by 9.5% and 7.5%, respectively) between 2010 and 2024, averaging 14.6%. With the combined use of traditional treatment and CBT (main group), the frequency of relapses of DA decreased by 5.5 times compared to the use of only drug “detoxification” (comparison group). Remission lasting ≥ 6 months to 1 year was observed 2.7 times more frequently in the study group than in the comparison group, and remission lasting more than 1 year was 22.0 times more frequent. Conclusions: In recent years, the incidence of DA has increased in the Samarkand region, while the remission rate has decreased. The use of CBT reduces the incidence of relapse, achieves long-term remission, and develops psychological adaptation strategies in patients.
References
Ашуров З.Ш., Хайрединова И.И., Ядгарова Н.Ф., Лян Е.М. Интегральная оценка факторов риска формирования полизависимости. Биология ва тиббиёт муаммолари 2022, №4 (137) стр. 21-25.
Бахрамов Ф.Ш. Оценка распространенности наркотической зависимости в г. Ташкенте // I съезд психиатров Узбекистана с международным участием. Материалы съезда. - Ташкент, 2015г. – С. 49
Кенжаева Н.К., Ризаев Ж.А., Умиров С.Э., Буриев А.Я. Истеъмол қилинадиган гиёҳванд моддалар тоифасининг беморлар соғайишига таъсири // Central Asian Research Journal For Interdisciplinary Studies (CARJIS). Volume 4, 2025, №4. – 116-125
Ризаев Ж.А., Умиров С.Э., Кенжаева Н.К. Гиёҳванд моддаларга тобелик шаклланишининг ҳудудий хусусиятлари // Биология ва тиббиёт муаммолари 1(145), бет-158-161
Global Burden of Disease (GBD) Study, 2023. Lancet Public Health, 2024; 9(2):e115–e134.
Degenhardt, L., Whiteford, H., Hall, W., et al. "The Global Epidemiology of Drug Use and Addiction." 2014, In: Global Mental Health and Drug Use. Cambridge University Press.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). "European Drug Report 2021."
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2024.
United Nations Office on Drugs and Crime (UNODC), 2021; "World Drug Report 2021." United Nations.
United Nations Office on Drugs and Crime (UNODC), 2024; "World Drug Report 2024." United Nations.
World Health Organization (WHO) (2024). "Global Status Report on Alcohol and Health." World Health Organization.